[VRAX] YoY Quarter Result on 31-Mar-2022 [#Q4]

Stock
[VRAX] Virax Biolabs Group Limited
Announcement Date
12-Aug-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q4]
Profit Trend
QoQ- -109.42%
YoY- -275.32%
Quarter Report
VRAX's Result
VRAX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
Revenue 80 3 -93 110 25 33.72%
PBT -3,825 -4,004 -1,175 -283 -185 113.12%
Tax 0 -4,282 17 -249 -8 -
NP -3,824 -4,014 -1,156 -308 -177 115.48%
Tax Rate - - - - - -
Total Cost 3,904 4,017 1,064 417 202 109.56%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
NP Margin -4,784.70 -143,301.79 1,245.26 -280.03 -708.85 61.13%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
EPS -1.71 -2.58 -1.02 -0.27 -0.02 203.85%
EPS Diluted -1.71 -2.58 -1.02 -0.27 -0.02 203.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.